Submitted by Anonymous (not verified) on 6 January 2025 - 16:30
Human medicines European public assessment report (EPAR): Ontruzant, trastuzumab, Date of authorisation: 15/11/2017, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ontruzant, trastuzumab, Date of authorisation: 15/11/2017, Revision: 15, Status: Authorised